Basiliximab
Generic name: Basiliximab
Brand names: Simulect
Dosage form: intravenous powder for injection (10 mg; 20 mg)
Drug class:
Interleukin inhibitors
Usage of Basiliximab
Basiliximab is used with other medications to prevent organ rejection after a kidney transplant. Basiliximab weakens your immune system to prevent your body from "rejecting" the transplanted kidney.
Basiliximab may also be used for purposes not listed in this medication guide.
Basiliximab side effects
Get emergency medical help if you have signs of an allergic reaction: hives, rash, itching; feeling like you might pass out; sneezing, wheezing, difficult breathing; fast heartbeats; swelling of your face, lips, tongue, or throat.
An allergic reaction may occur up to 24 hours after a basiliximab injection.
Basiliximab may cause serious side effects. Call your doctor at once if you have:
Common side effects of basiliximab may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Basiliximab
You should not use basiliximab if you are allergic to it.
Tell your doctor if you have ever had:
May harm an unborn baby. Use effective birth control while receiving basiliximab and for at least 4 months after your last dose. Tell your doctor if you become pregnant.
Do not breastfeed.
Relate drugs
- Actemra
- Actemra ACTPen
- Adbry
- Arcalyst
- Cosentyx
- Basiliximab
- Benralizumab
- Brodalumab
- Canakinumab
- Cinqair
- Daclizumab
- Dupilumab
- Dupixent
- Dupixent Pre-filled Pen
- Dupixent Pre-filled Syringe
- Enspryng
- Fasenra
- Fasenra Pen
- Fasenra Prefilled Syringe
- Guselkumab
- Ilaris
- Ilumya
- Ixekizumab
- Mepolizumab
- Nucala
- Reslizumab
- Rilonacept
- Risankizumab
- Risankizumab-rzaa
- Satralizumab
- Satralizumab-mwge
- secukinumab
- Siliq
- Siltuximab
- Simulect
- Skyrizi
- Skyrizi Pen
- Spesolimab
- Spesolimab-sbzo
- Spevigo
- Stelara
- Sylvant
- Taltz
- Tildrakizumab
- Tildrakizumab-asmn
- Tocilizumab
- Tralokinumab
- Tralokinumab-ldrm
- Tremfya
- Ustekinumab
- Zinbryta
How to use Basiliximab
Usual Adult Dose for Organ Transplant -- Rejection Prophylaxis:
20 mg by IV infusion over 20 to 30 minutes or by IV bolus injection within 2 hours before surgery and 4 days after transplantation; withhold the second dose if complications occur (e.g., severe hypersensitivity or graft loss)Comments:-This drug is used as part of an immunosuppressive regimen that includes cyclosporine and corticosteroids. Use: For the prophylaxis of acute organ rejection in patients receiving renal transplantation when used as part of an immunosuppressive regimen that includes cyclosporine and corticosteroids
Usual Pediatric Dose for Organ Transplant -- Rejection Prophylaxis:
One year and older:-Weight 35 kg or less: 10 mg by IV infusion over 20 to 30 minutes or by IV bolus injection within 2 hours before surgery and 4 days after transplantation; withhold the second dose if complications occur (e.g., severe hypersensitivity or graft loss)-Weight 35 kg or more: 20 mg by IV infusion over 20 to 30 minutes or by IV bolus injection within 2 hours before surgery and 4 days after transplantation; withhold the second dose if complications occur (e.g., severe hypersensitivity or graft loss)Comments:-This drug is used as part of an immunosuppressive regimen that includes cyclosporine and corticosteroids. Use: For the prophylaxis of acute organ rejection in patients receiving renal transplantation when used as part of an immunosuppressive regimen that includes cyclosporine and corticosteroids
Warnings
You may get infections or bleed more easily. Call your doctor if you have unusual bleeding or signs of infection (fever, cough, skin sores, painful urination).
What other drugs will affect Basiliximab
Other drugs may affect basiliximab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions